Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|April 14, 2010
Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjectsRobert Jordan, Jarasvech Chinsangaram, Tove' C Bolken, et al.Plos Biology|December 21, 2023
Early administration of tecovirimat shortens the time to mpox clearance in a model of human infectionBach Tran Nguyen, Aurélien Marc, Clara Suñer, et al.Antimicrobial Agents and Chemotherapy|April 25, 2012
Pharmacokinetic comparison of a single oral dose of polymorph form i versus form V capsules of the antiorthopoxvirus compound ST-246 in human volunteersJarasvech Chinsangaram, Kady M Honeychurch, Shanthakumar R Tyavanagimatt, et al.Antimicrobial Agents and Chemotherapy|April 8, 2009
Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246John Huggins, Arthur Goff, Lisa Hensley, et al.Plos Pathogens|February 22, 2024
Smallpox lesion characterization in placebo-treated and tecovirimat-treated macaques using traditional and novel methodsTodd M Bell, Paul Facemire, Jeremy J Bearss, et al.Antimicrobial Agents and Chemotherapy|December 21, 2012
Pharmacokinetic and pharmacodynamic modeling to determine the dose of ST-246 to protect against smallpox in humansJanet M Leeds, Frederique Fenneteau, Nathalie H Gosselin, et al.Antimicrobial Agents and Chemotherapy|October 9, 2013
Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox)Eric M Mucker, Arthur J Goff, Joshua D Shamblin, et al.Antiviral Research|March 5, 2011
Evaluation of Lassa antiviral compound ST-193 in a guinea pig modelKathleen A Cashman, Mark A Smith, Nancy A Twenhafel, et al.Memorias Do Instituto Oswaldo Cruz|July 12, 2023
In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimatDesiree Dos Santos Nunes, Luiza M Higa, Régis Linhares Oliveira, et al.Journal of Virology|January 18, 2008
Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challengeAklile Berhanu, Rebecca L Wilson, Dana L Kirkwood-Watts, et al.Pageof 9